Alpha-fetoprotein: A controversial prognostic biomarker for small hepatocellular carcinoma

被引:16
作者
Asrih, Mohamed [1 ]
Lenglet, Sebastien [1 ]
Mach, Francois [1 ]
Montecucco, Fabrizio [1 ,2 ]
机构
[1] Fdn Med Res, Univ Hosp Geneva, Dept Med, Div Cardiol, CH-1211 Geneva, Switzerland
[2] Univ Genoa, Dept Internal Med, Clin Internal Med 1, I-16126 Genoa, Italy
基金
瑞士国家科学基金会;
关键词
Hepatocellular carcinoma; Alpha-fetoprotein; Prognosis; Cirrhosis; Biomarker; HEPATITIS-C; SURVEILLANCE;
D O I
10.3748/wjg.v19.i3.328
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The assessment of the prognosis in patients with early hepatocellular carcinoma represents a hot-topic issue that requires further improvements and clarifications. The life expectancy of the patients has been shown to depend on several clinical and histological parameters (such as patient's general conditions, macroscopic tumor morphology and histopathology). Recently, the prognostic role of some biomarkers [i.e., alpha-fetoprotein (AFP)] has been also investigated with controversial findings mainly on the assessment of patient survival. The study by Giannini et al failed to show a prognostic value of AFP on survival of patients with well-compensated cirrhosis and small hepatocellular carcinoma. Since the study presents some limitations, a larger clinical trial is needed to clarify the potential prognostic role of serum AFP levels in these patients. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:328 / 330
页数:3
相关论文
共 18 条
[1]   PRODUCTION OF EMBRYONAL ALPHA-GLOBULIN BY TRANSPLANTABLE MOUSE HEPATOMAS [J].
ABELEV, GI ;
PEROVA, SD ;
KHRAMKOVA, NI ;
POSTNIKOVA, ZA ;
IRLIN, IS .
TRANSPLANTATION, 1963, 1 (02) :174-180
[2]   Modification of humoral immune response in C57Bl/6 mice with a complex of α-fetoprotein and retinoid acid derivatives [J].
Arsenov, DV ;
Golubeva, MB ;
Kisel, MA ;
Konoplya, NA ;
Lyubin, GS ;
Kuz'mitskii, BB ;
Strel'chenok, OA .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 132 (04) :963-965
[3]  
Bertino G, 2011, MINERVA MED, V102, P363
[4]   Serum alpha-fetoprotein predicts virologic response to Hepatitis C treatment in HIV coinfected patients [J].
Carrat, Fabrice ;
Bedossa, Pierre ;
Lunel-Fabiani, Francoise ;
Morand, Patrice ;
Pialoux, Gilles ;
Piroth, Lionel ;
Salmon-Ceron, Dorninique ;
Bani-Sadr, Firouze ;
Perronne, Christian ;
Cacoub, Patrice ;
Pol, Stanislas .
AIDS, 2008, 22 (12) :1513-1515
[5]   Screening for hepatocellular carcinoma [J].
Collier, J ;
Sherman, M .
HEPATOLOGY, 1998, 27 (01) :273-278
[6]   Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis [J].
Giannini, Edoardo G. ;
Marenco, Simona ;
Borgonovo, Giacomo ;
Savarino, Vincenzo ;
Farinati, Fabio ;
Del Poggio, Paolo ;
Rapaccini, Gian Ludovico ;
Di Nolfo, Maria Anna ;
Benvegnu, Luisa ;
Zoli, Marco ;
Borzio, Franco ;
Caturelli, Eugenio ;
Chiaramonte, Maria ;
Trevisani, Franco .
HEPATOLOGY, 2012, 56 (04) :1371-1379
[7]   Structure and function of α-fetoprotein:: a biophysical overview [J].
Gillespie, JR ;
Uversky, VN .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1480 (1-2) :41-56
[8]  
Haibin Z, 2010, EUR J GYNAECOL ONCOL, V31, P682
[9]   Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection [J].
Li, Tao ;
Qin, Lun-Xiu ;
Gong, Xiao ;
Zhou, Jian ;
Sun, Hui-Chuan ;
Qiu, Shuang-Jian ;
Ye, Qing-Hai ;
Wang, Lu ;
Fan, Jia .
CANCER, 2013, 119 (01) :126-135
[10]   Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma [J].
Llovet, Josep M. ;
Pena, Carol E. A. ;
Lathia, Chetan D. ;
Shan, Michael ;
Meinhardt, Gerold ;
Bruix, Jordi .
CLINICAL CANCER RESEARCH, 2012, 18 (08) :2290-2300